Statins: so much has changed in 30 years
Just when we thought that cholesterol and statins were old news, recent studies and new medicines have resulted in a changed approach.
Have we finally resolved the issue of LDL reduction and what to target? What about HDL cholesterol? Triglycerides?
Should we deprescribe?
This session will take an evidence-based but pragmatic approach to prescribing, considering individuals and populations.